L97 Stock Overview
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Yonghe Medical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.12 |
| 52 Week High | HK$0.88 |
| 52 Week Low | HK$0.09 |
| Beta | 0.30 |
| 1 Month Change | 10.38% |
| 3 Month Change | -22.00% |
| 1 Year Change | -84.61% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -93.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| L97 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 3.5% | -1.8% | 1.8% |
| 1Y | -84.6% | -3.5% | 4.2% |
Return vs Industry: L97 underperformed the German Healthcare industry which returned -3.5% over the past year.
Return vs Market: L97 underperformed the German Market which returned 4.2% over the past year.
Price Volatility
| L97 volatility | |
|---|---|
| L97 Average Weekly Movement | 41.2% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L97's share price has been volatile over the past 3 months.
Volatility Over Time: L97's weekly volatility has increased from 22% to 41% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 4,319 | Yu Zhang | www.yonghegroup.cn |
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; and wig business.
Yonghe Medical Group Co., Ltd. Fundamentals Summary
| L97 fundamental statistics | |
|---|---|
| Market cap | €72.78m |
| Earnings (TTM) | -€69.29m |
| Revenue (TTM) | €228.95m |
0.3x
P/S Ratio-1.1x
P/E RatioIs L97 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L97 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.78b |
| Cost of Revenue | CN¥780.07m |
| Gross Profit | CN¥997.19m |
| Other Expenses | CN¥1.54b |
| Earnings | -CN¥537.86m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.07 |
| Gross Margin | 56.11% |
| Net Profit Margin | -30.26% |
| Debt/Equity Ratio | 16.2% |
How did L97 perform over the long term?
See historical performance and comparison